NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Axonics Inc (NASDAQ: AXNX)

 
AXNX Technical Analysis
5
As on 14th Nov 2024 AXNX STOCK Price closed @ 70.43 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 59.68 & Strong Buy for SHORT-TERM with Stoploss of 53.16 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

AXNXSTOCK Price

Open 70.50 Change Price %
High 70.50 1 Day -0.04 -0.06
Low 70.37 1 Week 0.12 0.17
Close 70.43 1 Month 1.02 1.47
Volume 148977 1 Year 22.30 46.33
52 Week High 70.49 | 52 Week Low 47.99
 
NASDAQ USA Most Active Stocks
AMRS 0.14 100.00%
PCSA 0.26 13.04%
GNLN 0.01 0.00%
ACXP 0.82 164.52%
HCTI 0.02 -33.33%
LCID 2.15 0.00%
NVDA 144.12 -0.39%
LMDX 0.02 0.00%
RUN 5.78 -40.04%
AKTS 0.04 0.00%
 
NASDAQ USA Top Gainers Stocks
ZWZZT 26.52 3688.57%
KTRA 6.30 2763.64%
FGEN 5.88 2077.78%
FGEN 5.88 2077.78%
FGEN 5.88 2077.78%
IDRA 8.64 1909.30%
SNSE 6.55 1884.85%
REDU 3.41 1075.86%
RAPT 7.84 661.17%
CTXRW 0.14 600.00%
 
NASDAQ USA Top Losers Stocks
SRAX 0.00 -100.00%
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
NBSTU 2.00 -82.44%
TBIO 0.05 -80.00%
ACAQ-UN 2.50 -73.49%
AGBA 0.35 -71.31%
AXAS 0.03 -70.00%
BPTH 0.21 -66.67%
AXDX 0.03 -66.67%
 
 
AXNX
Daily Charts
AXNX
Intraday Charts
Whats New @
Bazaartrend
AXNX
Free Analysis
 
AXNX Important Levels Intraday
RESISTANCE70.68
RESISTANCE70.60
RESISTANCE70.55
RESISTANCE70.50
SUPPORT70.36
SUPPORT70.31
SUPPORT70.26
SUPPORT70.18
 
AXNX Forecast June 2025
4th UP Forecast101.07
3rd UP Forecast91.24
2nd UP Forecast85.17
1st UP Forecast79.1
1st DOWN Forecast61.76
2nd DOWN Forecast55.69
3rd DOWN Forecast49.62
4th DOWN Forecast39.79
 
AXNX Weekly Forecast
4th UP Forecast78.87
3rd UP Forecast76.16
2nd UP Forecast74.49
1st UP Forecast72.82
1st DOWN Forecast68.04
2nd DOWN Forecast66.37
3rd DOWN Forecast64.70
4th DOWN Forecast61.99
 
AXNX Forecast2025
4th UP Forecast115.02
3rd UP Forecast100.72
2nd UP Forecast91.88
1st UP Forecast83.04
1st DOWN Forecast57.82
2nd DOWN Forecast48.98
3rd DOWN Forecast40.14
4th DOWN Forecast25.84
 
 
AXNX Other Details
Segment EQ
Market Capital 3375661312.00
Sector Healthcare
Industry Medical Devices
Offical website >
 
AXNX Address
AXNX
 
AXNX Latest News
 
Your Comments and Response on Axonics Inc
 
AXNX Business Profile
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention. Its proprietary rechargeable SNM System (r-SNM) delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of bladder and bowel dysfunction. The company also offers Bulkamid, a urethral bulking agent to treat female stress urinary incontinence. It sells its products through a direct salesforce and distributors in the United States, the United Kingdom, Germany, France, Nordic countries, and internationally. The company was formerly known as Axonics Modulation Technologies, Inc. and changed its name to Axonics, Inc. in March 2021. Axonics, Inc. was incorporated in 2012 and is headquartered in Irvine, California. Address: 26 Technology Drive, Irvine, CA, United States, 92618
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service